当前位置:主页 > 医学论文 > 传染病论文 >

CXC趋化因子配体10与病毒性肝炎研究进展

发布时间:2018-12-09 08:39
【摘要】:在病毒性肝炎疾病进展的过程之中,淋巴细胞向受病毒感染的肝组织迁移及侵润,对抗病毒免疫应答和炎症反应的发生起着至关重要的作用,但对其机理的研究尚未取得令人满意的答案。近几年来,CXC趋化因子配体(CXC chemokine ligand,CXCL)10是目前研究较多的一个细胞因子,其受体是CXCR3,两者之间的相互作用已成为病毒性肝炎的发生及发展机制的重要突破点。本文就CXCL10在病毒性肝炎中的意义及对抗病毒疗效评估的相关研究进展作一综述。CXCL10,又名干扰素γ诱导蛋白10,属于CXC亚家族中的ELR—趋化因子,CXCL10主要与趋化因子受体CXCR3结合而发挥作用,其主要作用包括促进细胞趋化、诱导细胞凋亡、调节细胞生长和增殖及调节血管生成等;多项研究显示,慢性HBV、HCV感染者血清及肝组织CXCL10表达水平增高,且随着肝脏炎症及纤维化程度的加重,CXCL10水平也随之增加,提示了CXCL10在肝脏病理损伤过程中可能发挥了重要的作用;在应用抗HBV、HCV药物治疗后,血清CXCL10水平逐渐下降,提示CXCL10在病毒清除过程中可能发挥了重要作用,并发现血清CXCL10基线水平及治疗过程中CXCL10的下降幅度可能有效预测抗病毒疗效。但CXCL10参与病毒性肝炎病理过程的机制及在抗病毒治疗过程中的作用机制尚不清楚,仍需要进一步研究。
[Abstract]:In the progress of viral hepatitis disease, lymphocyte migration and infiltration into the infected liver tissue, anti-viral immune response and inflammatory response plays a vital role. However, the study of its mechanism has not yet obtained a satisfactory answer. In recent years, CXC chemokine ligand (CXC chemokine ligand,CXCL) 10 is one of the most widely studied cytokines. Its receptor is an important breakthrough point of the mechanism of occurrence and development of viral hepatitis. This article reviews the significance of CXCL10 in viral hepatitis and the related research progress in the evaluation of antiviral efficacy. CXCL10, also known as interferon 纬 inducible protein 10, belongs to the ELR- chemokine in the CXC subfamily. CXCL10 mainly binds to chemokine receptor CXCR3. Its main functions include promoting cell chemotaxis, inducing apoptosis, regulating cell growth and proliferation, and regulating angiogenesis. A number of studies have shown that the expression of CXCL10 in serum and liver tissues of chronic HBV,HCV infected patients increased, and with the severity of liver inflammation and fibrosis, the level of CXCL10 also increased. The results suggest that CXCL10 may play an important role in the process of liver pathological injury. The level of serum CXCL10 decreased gradually after treatment with antiviral HBV,HCV drugs, suggesting that CXCL10 may play an important role in the process of virus clearance. It was found that the baseline level of serum CXCL10 and the decrease of CXCL10 in the course of treatment might be effective in predicting the antiviral effect. However, the mechanism of CXCL10 involved in the pathological process of viral hepatitis and its role in antiviral therapy are still unclear, and need to be further studied.
【学位授予单位】:河北医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R512.6

【参考文献】

相关期刊论文 前10条

1 郝洁;田小军;宋新文;申保生;段树鹏;;聚乙二醇干扰素对慢性丙肝患者血清炎症细胞因子及抗体水平的影响[J];山东医药;2016年40期

2 张健;吴友伟;吕飒美;史丽萍;周健;;血清IP-10 MIG IL-8及RANTES水平变化与肝癌进展关系分析[J];西部医学;2015年09期

3 苏然;熊亚莉;刘勇;黄睿;王贵阳;严晓敏;陈军浩;吴超;;不同免疫状态下慢性HBV感染者外周血调节性B细胞及血清IL-10和IP-10的表达特点[J];中华实验和临床感染病杂志(电子版);2015年04期

4 李晓阳;张强;易显富;袁情;唐文娟;;趋化因子CXCL10启动子区-201G/A多态性与慢性乙型肝炎易感相关性研究[J];海南医学;2015年14期

5 王可宁;杨红园;褚瑞海;刘松;曲孝阳;;血清趋化因子IP-10在慢性HBV感染者中的表达及意义[J];辽宁医学院学报;2015年02期

6 Francesca Capone;Eliana Guerriero;Giovanni Colonna;Patrizia Maio;Alessandra Mangia;Giuseppe Castello;Susan Costantini;;Cytokinome profile evaluation in patients with hepatitis C virus infection[J];World Journal of Gastroenterology;2014年28期

7 王亚东;张莉;申川;曹伟;赵亚娟;甄真;赵彩彦;;慢性乙型肝炎病毒感染者不同阶段γ干扰素及其诱导蛋白10表达变化[J];中华传染病杂志;2014年01期

8 李文莉;吴茂盛;黄育波;朱计芬;刘细玲;许瑞荣;;干扰素α-2b对慢性乙型肝炎患者血清干扰素诱导蛋白、活性调节蛋白水平的影响[J];中国基层医药;2012年09期

9 杨华;罗亚文;刘华庆;侯文;李佳;;慢性乙型肝炎患者肝组织CXCR3及其配体IP 10表达与肝脏炎症程度、纤维化的相关性研究[J];第三军医大学学报;2012年03期

10 李绍民;刘国华;邓李玲;;替比夫定对慢性乙型肝炎患者外周血IP-10、Fractalkine水平影响及其临床意义的探讨[J];黑龙江医药科学;2012年01期



本文编号:2369103

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/chuanranbingxuelunwen/2369103.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户bf81f***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com